---
schema_version: "secwatch.filing_event.v1"
accession: "0001413329-25-000006"
form_type: "8-K"
ticker: "PM"
cik: "0001413329"
company_name: "Philip Morris International Inc."
filed_at: "2025-01-16T23:59:59+00:00"
generated_at: "2026-05-27T23:53:07.367263+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# FDA authorizes all ZYN nicotine pouches, first authorized nicotine pouch in US

## Summary
- FDA granted marketing authorization for all 20 ZYN nicotine pouch variants (3 mg and 6 mg) marketed by Swedish Match.
- Decision positions ZYN as the first FDA-authorized nicotine pouch, offering a better alternative to cigarettes.
- PMI subsidiary Swedish Match North America cited ~30M US adult smokers as target for switching.
- Authorization covers flavors: Cool Mint, Peppermint, Spearmint, Wintergreen, Citrus, Coffee, Cinnamon, Smooth, Chill, Menthol.

## SEC filing metadata
- accession: 0001413329-25-000006
- form_type: 8-K
- ticker: PM
- cik: 0001413329
- company_name: Philip Morris International Inc.
- filed_at: 2025-01-16T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1413329/000141332925000006/0001413329-25-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1413329/000141332925000006/pm-20250116.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001413329-25-000006
- JSON: https://secwatch.observer/filing/0001413329-25-000006.json
- Plain text: https://secwatch.observer/filing/0001413329-25-000006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.